Related Experiment Videos
Clinical effects of different protamine doses after cardiopulmonary bypass
1Oslo Heart Center, Oslo, Norway. peter.svenarud@thsurg.hs.sll.se
Insights
Determining the optimal protamine dose after cardiopulmonary bypass is crucial. A 1.3 mg protamine to 1 mg heparin ratio proved safe and effective in neutralizing heparin, reducing transfusion needs.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Pharmacology
Background:
- Heparin is widely used for anticoagulation during cardiopulmonary bypass (CPB).
- Protamine sulfate is the standard reversal agent for heparin, but optimal dosing remains debated.
- Uncertainty exists regarding the most effective protamine dosage to neutralize heparin's anticoagulant effects post-CPB.
Purpose of the Study:
- To compare the efficacy and safety of three different protamine sulfate dosing regimens for heparin reversal after CPB.
- To identify the optimal protamine dose to minimize complications such as blood transfusion and bleeding.
Main Methods:
- Retrospective cohort study of 300 patients undergoing coronary artery bypass grafting (CABG).
- Patients were divided into three groups receiving different protamine to heparin ratios: 1.3:1 (Group A), 0.75:1 (Group B), and fractionated doses (Group C).
- Clinical outcomes including red cell transfusion, resternotomy for bleeding, mediastinal drainage, and hemoglobin loss were analyzed.
Main Results:
- Group B (0.75 mg protamine/mg heparin) showed a significantly higher rate of red cell transfusion compared to Groups A and C.
- A trend towards increased resternotomy, mediastinal drainage, and hemoglobin loss was observed in Group B, though not statistically significant.
- Group A (1.3 mg protamine/mg heparin) demonstrated safe and efficient heparin neutralization.
Conclusions:
- A single bolus dose of 1.3 mg protamine per 1 mg heparin is a safe and effective strategy for neutralizing heparin after cardiopulmonary bypass.
- Lower protamine doses (0.75 mg/mg) may be associated with increased transfusion requirements and bleeding complications.
- Further research may refine protamine dosing protocols in cardiac surgery.
Abstract:
The optimal dose of protamine needed to reverse the anticoagulant effect of heparin after cardiopulmonary bypass is still not known. In this retrospective cohort study, we investigated 3 different dose regimes in 300 patients undergoing coronary artery bypass grafting. Group A patients (n = 100) were given protamine in the ratio of 1.3 mg to 1 mg heparin, group B patients (n = 100) were given 0.75 mg protamine to 1 mg heparin, and group C patients (n = 100) were given protamine in fractionated doses of 1 mg + 0.15 mg + 0.15 mg to 1 mg heparin. The groups were comparable in all major clinical and operative variables. The heparin dose was almost identical in the groups. The rate of red cell transfusion was significantly higher in group B than in the other groups. A similar but nonsignificant trend was observed in the incidence of resternotomy for postoperative bleeding, mediastinal drainage, and postoperative hemoglobin loss. The study demonstrates that a single bolus dose of 1.3 mg protamine to 1 mg heparin is safe and efficient for neutralizing heparin after cardiopulmonary bypass.